Managing the patient with psychiatric issues in dermatologic practice

Clinics in Dermatology

Volumn 31, Issue 1, 2013, Pages 3-10

  Gordon Elliott, Janna S ^a   Muskin, Philip R ^b,c,d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c Department of Medicine   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NALTREXONE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ANXIETY; AUTOMUTILATION; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BIPOLAR DISORDER; BODY DYSMORPHIC DISORDER; CLINICAL EVALUATION; CLINICAL PRACTICE; COMORBIDITY; CONVERSION DISORDER; DELUSIONAL PARASITOSIS; DERMATOLOGY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISTRESS SYNDROME; DOCTOR PATIENT RELATION; FACTITIOUS DISEASE; HELP SEEKING BEHAVIOR; HIGH RISK PATIENT; HUMAN; HYPOCHONDRIASIS; HYPOPHYSIS ADRENAL SYSTEM; IMPULSE CONTROL DISORDER; MAJOR DEPRESSION; MELANOMA; MENTAL DISEASE; MORTALITY; NOTE; PATIENT PARTICIPATION; PATIENT SAFETY; PRIORITY JOURNAL; PRURITUS; PSYCHIATRIC TREATMENT; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RELAXATION TRAINING; SKIN ULCER; SOCIAL ISOLATION; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; TREATMENT PLANNING; TRICHOTILLOMANIA;

DERMATOLOGY; FACTITIOUS DISORDERS; HUMANS; PHYSICIAN-PATIENT RELATIONS; PSYCHOPHYSIOLOGIC DISORDERS; SKIN DISEASES; STRESS, PSYCHOLOGICAL;

EID: 84871099349     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.11.001     Document Type: Note

References (33)

1. Tausk F., Elenkov I., Moynihan J. Psychoneuroimmunology. Dermatol Ther 2008, 21:22-31.
2. Gupta M.A. Somatization disorders in dermatology. Int Rev Psychiatry 2006, 18:41-47.
3. Lee C.S. Delusions of parasitosis. Dermatol Ther 2008, 21:2-7.
4. Johnson G.C., Anton R.F. Delusions of parasitosis: differential diagnosis and treatment. South Med J 1985, 78:914-918.
5. Wykoff R.F. Delusions of parasitosis: a review. Rev Infect Dis 1987, 9:433-437.
6. Lee W.R. Matchbox sign. Lancet 1983, 2:457-458.
7. Gould W.M., Gragg T.M. Delusions of parasitosis: an approach to the problem. Arch Dermatol 1976, 112:1745-1748.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000. p. 485-517;674-7.
9. Yosipovitch G., Samuel L.S. Neuropathic and psychogenic itch. Dermatol Ther 2008, 21:32-41.
10. Fjellner B., Arnetz B.B., Eneroth P., et al. Pruritus during standardized mental stress: relationship to psychoneuroendocrine and metabolic parameters. Acta Derm Venereol 1985, 65:199-205.
11. Phillips K.A. Suicidality in body dysmorphic disorder. Prim Psychiatry 2007, 14:58-66.
12. Appelbaum P.S., Grisso T. Capacities of hospitalized, medically ill patients to consent to treatment. Psychosomatics 1997, 38:119-125.
13. Muskin P.R., Feldhammer T., Gelfand J.L., et al. Maladaptive denial of physical illness: a useful new ' diagnosis.' Int J Psychiatry Med 1998, 28:463-477.
14. Koblenzer C.S. Psychocutaneous Disease 1987, Grune & Stratton, Orlando, FL.
15. Stein D.J., Hollander E. Dermatology and conditions related to obsessive-compulsive disorder. J Am Acad Dermatol 1992, 26:237-242.
16. Hollender M.H., Abram H.S. Dermatitis factitia. South Med J 1973, 66:1279-1285.
17. Sambhi R., Lepping P. Psychiatric treatments in dermatology: an update. Clin Exp Dermatol 2010, 35:120-125.
18. Gupta M.A., Gupta A.K. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003, 4:833-842.
19. Arnold L.M., Auchenbach M.B., McElroy S.L. Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs 2001, 15:351-359.
20. Cohen L.J., Stein D.J., Simeon D., et al. Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study. J Clin Psychiatry 1995, 56:319-326.
21. Duke D.C., Keeley M.L., Geffken G.R., et al. Trichotillomania: a current review. Clin Psychol Rev 2010, 30:181-193.
22. Lee C.S., Accordino R., Howard J., et al. Psychopharmacology in dermatology. Dermatol Ther 2008, 21:69-82.
23. Fried R.G., Hussain S.H. Nonpharmacologic management of common skin and psychocutaneous disorders. Dermatol Ther 2008, 21:60-68.
24. Gupta M.A., Gupta A.K. Psychodermatology: an update. J Am Acad Dermatol 1996, 34:1030-1046.
25. Filaković P., Petek A., Koić O., et al. Comorbidity of depressive and dermatologic disorders-therapeutic aspects. Psychiatr Danub 2009, 21:401-410.
26. Hughes J., Barraclough B., Hamblin L., et al. Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983, 143:51-54.
27. Hong J., Koo B., Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther 2008, 21:54-59.
28. Goldberg D.P., Gater R., Sartorius N., et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 1997, 27:191-197.
29. Ware J.E., Snow K.K., Kosinksi M. SF-36 Health Survey Manual and Interpretation Guide 1993, The Health Institute, New England Medical Center, Boston.
30. Finlay A.Y., Khan G.K. Dermatology life quality index (DLQI: a simple practical measure for routine clinical use). Clin Exp Dermatol 1994, 19:210-216.
31. Bronsard V., Paul C., Prey S. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol 2010, 24:17-22.
32. Goodwin R.D., Marusic A., Hoven C.W. Suicide attempts in the United States: the role of physical illness. Soc Sci Med 2003, 56:1783-1788.
33. Karasu T.B., Waltzman S.A., Lindenmayer J.P., et al. The medical care of patients with psychiatric illness. Hosp Community Psychiatry 1980, 31:463-472.